skip to content

Cambridge Academy of Therapeutic Sciences

Read more at: MPhil in Therapeutic Sciences

MPhil in Therapeutic Sciences

The University of Cambridge and The Cambridge Academy of Therapeutic Sciences are delighted to launch the new and innovative MPhil in Therapeutic Sciences in Autumn 2018, with the first cohort of students due to begin in Autumn 2019. This one-year full-time course will select a cohort of students with the skills...

Read more

Read more at: Industry Experts in Residence (EiRs)

Industry Experts in Residence (EiRs)

Our Industry Experts in Residence are available to University of Cambridge staff for: Advice on the applicability of specific ideas to drug discovery, diagnostics & devices Advice on translational grant applications Discussions about progression of current translational research projects Work in conjunction with...

Read more


Read more at: Open Access to Drug Discovery

Open Access to Drug Discovery

The folllowing companies and not-for-profit organisations offer services and tools which support drug discovery. AstraZeneca BioAscent EMBL-EBI EU-OPENSCREEN GSK UCB AstraZeneca AstraZeneca have a number of offerings under their OpenInnovation platform including: Clinical Compound Bank Preclinical Toolbox Target Innovation...

Read more

Read more at: WT Developing Concept Fund and MRC Confidence in Concept fund

WT Developing Concept Fund and MRC Confidence in Concept fund

WT Developing Concept Fund and MRC Confidence in Concept fund CATS and OTR invite you to submit applications for internal pump-priming funding for biomedical translational research. The MRC Confidence in Concept fund is intended to accelerate the transition from discovery research to translational development projects by...

Read more


Latest news

Nanoparticles used to transport anti-cancer agent to cells

18 September 2019

Scientists from the University of Cambridge have developed a platform that uses nanoparticles known as metal-organic frameworks to deliver a promising anti-cancer agent to cells. We focus on difficult diseases such as hard-to-treat cancers for which there has been no improvement in treatment in the last 20 years David...

New stem cell combination could help to repair damaged hearts

13 August 2019

A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research by scientists at the University of Cambridge, published in Nature Biotechnology . Our research shows the huge potential of stem cells for one day becoming...